Eisai to Divest Rights for Anti-Epileptic Drug Fycompa CIII in US to Catalyst Pharmaceuticals

2 min read
Fander Falconi | Eisai to Divest Rights for Anti-Epileptic Drug Fycompa CIII in US to Catalyst Pharmaceuticals...